According to the World Health Organization, about 42% of all blindness is due to cataracts. A cataract forms when the lens behind the colored part of your eye becomes cloudy. Degradation of eye tissue can reduce the clarity of images when the tissue clumps together. Over time, the thickness of the clumped tissue increases and can lead to partial or complete blindness.
While there are several types of cataracts, each type shares many of the same causes.
I've been receiving a lot of questions about cataracts, and the three big questions I will address today are:
When is it time to do cataract surgery?
What is the best lens to put in your eye?
What can you do post-surgically to improve your eye health?
🔴SUBSCRIBE to my channel for more holistic approaches to eye health!🔴
https://www.youtube.com/sberneod
To learn more about how you may address the causative factors of Cataracts go to:
https://www.drsamberne.com
Have questions? Join me on Facebook Live each week at 5pm PST.
https://facebook.com/samberneod
Disclaimer: The information presented is intended for educational purposes only. The information presented is in no way intended as a substitute for receiving professional medical care.
Castor Oil To Dissolve Cataracts, Dry Eyes, Glaucoma And Other Eye Pro (...)
The medical profession tells us that surgery is the only option for removing cataracts. While surgery may be the best option for treating an advanced case of cataracts ...
4 Ways to Keep From Losing Your Eyesight Cataracts GreenMedInfo
As we age our eyes gradually cloud over, with unchecked cataracts the leading cause of blindness. Here are 4 simple things you can do to make sure your eyes stay youthful late into life
A soft spot for stem cells helps cornea healing -- ScienceDaily
New research reveals a potential revolutionary way to treat eye injuries and prevent blindness -- by softening the tissue hosting the stem cells which then helps repair wounds, inside the body.
Activation of the molecular chaperone, sigma 1 receptor, preserves con (...)
The role of sigma 1 receptor (Sig1R) in rescuing cone photoreceptor function was investigated in Pde6β rd10 ( rd10 ) mice, a model of severe retinal degeneration. Sig1R, a putative molecular chaperone, is implicated in several human neurodegenerative diseases. We administered (+)-pentazocine, a high-affinity Sig1R ligand, to rd10 mice, which lose rod and subsequently cone photoreceptor cells (PRC) within the first few weeks of life, rendering them completely blind. Regular administration of (+)-pentazocine rescued cone PRC responses, which were markedly preserved and were similar to those in wild-type mice. To our knowledge, this is the first demonstration of significant preservation of retinal function as a consequence of Sig1R activation. The data are highly relevant to potential therapeutic interventions in human retinal disease.
Age-related macular degeneration before and after the era of anti-VEGF (...)
In a study of nearly 650 people with the eye disease age-related macular degeneration (AMD), half still had vision 20/40 or better, typically good enough to drive or to read standard print, after five years of treatment with anti-VEGF drugs that are injected into the eye. The authors of the study say those outcomes would have been unimaginable about 10 years ago, prior to the drugs' availability.
Aloe vera extract activity on human corneal cells. - PubMed - NCBI
Aloe vera contains multiple pharmacologically active substances which are capable of modulating cellular phenotypes and functions. Aloe vera ethanol and ethyl acetate extracts may be used in eye drops to treat inflammations and other ailments of external parts of the eye such as the cornea.
Angiogenesis factor found to promote three age-related diseases of the (...)
Increased expression of the angiogenic factor VEGF-A promotes three common aging-related eye conditions - both versions of age-related macular degeneration and also cataracts - in an animal model, report scientists.
Biomolecules Free Full-Text Trehalose for Ocular Surface Health
Trehalose is a natural disaccharide synthesized in various life forms, but not found in vertebrates. An increasing body of evidence demonstrates exceptional bioprotective characteristics of trehalose. This review discusses the scientific findings on potential functions of trehalose in oxidative stress, protein clearance, and inflammation, with an emphasis on animal models and clinical trials in ophthalmology. The main objective is to help understand the beneficial effects of trehalose in clinical trials and practice, especially in patients suffering from ocular surface disease. The discussion is supplemented with an overview of patents for the use of trehalose in dry eye and with prospects for the 2020s.
Blue-eyed humans have a single, common ancestor -- ScienceDaily
New research shows that people with blue eyes have a single, common ancestor. Scientists have tracked down a genetic mutation which took place 6,000-10,000 years ago and is the cause of the eye color of all blue-eyed humans alive on the planet today.
Blurred Vision Everything You Need to Know! Healing the Eye
It's important to know the causes of blurred vision to aid in prevention. This guide takes you through both the painless and painful causes of hazy vision.
Coconut Oil Protects Against Macular Degeneration GreenMedInfo
If you’re experiencing deteriorating vision as you age and don’t want to believe that it’s an unavoidable reality, the results of a recent study on macular degeneration will give you good reasons to get wide-eyed: coconut oil can now add “retina protection” to its long list of health benefits
Comparison of efficacy of trehalose-based eye drops versus topical 0.1% Hyaluronic Acid for management of clinically significant dry eye using non-invasive investigational modalities SpringerLink
Purpose To compare the efficacy of trehalose-HA eye drops versus 0.1% hyaluronic acid for the treatment of dry eye. Methods This prospective, comparative, contralateral eye study included sixty eligible patients (mean age 44.13 ± 14.53 years). Patients having a SPEED questionnaire score of 16 or above, objective scatter index (OSI) > 1 and non-invasive tear break up time (NIBUT) of 10 s or less were included in the study. Eyes were randomized to receive 0.1% hyaluronic acid (HA) in one eye and trehalose-HA eye drops in the contralateral eye. At baseline, 1- and 3-month follow-ups, OSI, NIBUT, MG loss, tear meniscus height (TMH) and tear film osmolarity (TFO) were evaluated using non-invasive modalities Results There was a statistically significant improvement in NIBUT, TMH, OSI, SPEED questionnaire score in the trehalose-HA compared to the 0.1% HA group at both 1- and 3-month visits (p
Comparison of the effect of a hyaluronate-trehalose solution to hyaluronate alone on Ocular Surface Disease Index in patients with moderate to seve... - PubMed - NCBI
This data supports the addition of trehalose to HA-containing eyedrop solutions to provide better symptomatic relief from moderate to severe DED, based on an OSDI score of
Contact lenses alter eye bacteria, making it more skin-like -- Science (...)
Contact lenses may alter the natural microbial community of the eyes, according to a study. In a study of 58 adults seeking outpatient eye care, researchers found that contact lenses make the eye microbiome more skin-like, with higher proportions of skin bacteria.
Current stimulation to the brain partially restores vision in patients (...)
Vision loss due to glaucoma or optic nerve damage is generally considered irreversible. Now a new prospective, randomized, multi-center clinical trial demonstrates significant vision improvement in partially blind patients after 10 days of noninvasive, transorbital alternating current stimulation. In addition to activation of their residual vision, patients also experienced improvement in vision-related quality of life such as acuity, reading, mobility or orientation.
Disease etiology-based design of multifunctional trehalose emulsion eye drops for moderate or severe dry eye a randomised, quadruple-masked and active-controlled clinical trial
Purpose To assess the safety and efficacy of multi-ingredient trehalose emulsion eye drops (TEED) designed to target (1) tear film instability, (2) tear hyperosmolarity, and (3) ocular surface damag...